Initial EU approval for Onglyza

Onglyza (saxagliptin) has received a CHMP positive opinion as add-on therapy to improve glycaemic control in adult patients with type 2 diabetes. The...

Roche ‘walks away’ from ABPI

Roche has decided not to review its membership of the ABPI in a controversial move that has led analysts to question the effectiveness of...

J&J and Elan form Alzheimer’s agreement

Johnson & Johnson is to acquire the Elan Corporation’s Alzheimer's Immunotherapy Program (AIP Program), through a newly-formed company. As part of the...

HRA Pharma establishes UK presence

HRA Pharma has established a UK subsidiary, HRA Pharma UK Ltd, based in London. This is the company’s second subsidiary in Europe as...

First pediatric PAH therapy approved in EU

Actelion’s pediatric dispersible formulation of Tracleer (bosentan) for the treatment of pulmonary arterial hypertension (PAH) has been approved in the EU. The approval...

Pfizer triumphs at environmental awards

Pfizer has been recognised as a leader in environmental excellence at the recent Business Commitment to the Environment (BCE) awards. Twelve companies received recognition...

CORRECTION: MabThera recommended in Scotland

Scottish physicians are now able to prescribe MabThera (rituximab) on the NHS, following a positive recommendation by the Scottish Medicines Consortium (SMC). MabThera was...

GPs need swine flu guidance

A poll of GPs by has revealed that, so far, only 9% of GPs in the UK have been given regular, clear and concise...

Tamiflu discount for poorer countries

Roche is to provide its antiviral Tamiflu at a lower price to developing countries as part of a new initiative. Under the Tamiflu Reserves...

Viruses resistant to Tamiflu identified

Several cases of the H1N1 ‘swine flu’ virus have emerged that are resistant to antiviral drug Tamiflu (oseltaminvir). WHO has been informed by...

Latest articles

First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

The world’s first Alzheimer’s disease (AD) drug candidate designed by artificial intelligence (AI) is entering Phase I clinical trials, thanks to a successful collaboration...
Colin Prentice, Commercial Director at Evolve

Expand and evolve – when specialist services meet

Specialist recruitment and outsourcing consultancy, Evolve, is pleased to announce the integration of Prentice Associates Ltd. The two specialist organisations have both provided recruitment...
NHS launches £160m initiative to tackle waiting lists

NHS launches £160m initiative to tackle waiting lists

The NHS has announced a £160 million initiative to tackle waiting lists and develop a blueprint for elective recovery as early reports show the...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Chiesi launches new virtual learning and support platform for respiratory nurses

Chiesi launches new virtual learning and support platform for respiratory nurses

A new education platform that brings together nurses on an online community has launched to coincide with International Nurses Day 2021. Chiesi Limited has launched...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
NHS launches £160m initiative to tackle waiting lists

NHS launches £160m initiative to tackle waiting lists

The NHS has announced a £160 million initiative to tackle waiting lists and develop a blueprint for elective recovery as early reports show the...
Image of a number of blocks and levels with different icons including magnifying glass, target, steps and graphs to show Coronavirus clinical research brought together in free information centre

Understanding the role of the MSL

Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription